Am J Transplant, Volume 5, Suppl 3 Archives - Page 82 of 170 - ATC Abstracts

2015 American Transplant Congress
Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients
B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.
University of Cincinnati, Cincinnati.
Background: Contrast-induced nephropathy (CIN) is associated with a significant increase in mortality and morbidity in patients with native kidneys. Data regarding CIN in renal allografts…
2015 American Transplant Congress
Interrogation of Plasma Cell-Rich Acute Rejection in Human Kidney Allografts by Whole Transcriptome Sequencing
L. Mesnard, F. Campagne, H. Yang, D. Dadhania, J. Lee, S. Seshan, M. Suthanthiran, T. Muthukumar.
Weill Medical College of Cornell University, New York.
Plasma cell-rich acute rejection (PCRAR, plasma cells constituting >20% of the allograft infiltrating cells) portends poor prognosis.To gain better mechanistic insights and develop diagnostic biomarkers,…
2015 American Transplant Congress
First Dose Tacrolimus Level Is Better Than CYP3A5 Genotyping in Prediction of Target Tacrolimus Dose
N. Townamchai,¹ W. Chancharoenthana,¹ S. Wattanatorn,¹ S. Vadcharavivad,² P. Chariyavilaskul,³ A. Leelahavanichkul,⁴ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
¹Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ²Department of Pharmacy Practice, Chulalongkorn University, Bangkok, Thailand; ³Pharmacokinetic Research Unit, Chulalongkorn University, Bangkok, Thailand; ⁴Department of Microbiology, Chulalongkorn University, Bangkok, Thailand.
Background: Tacrolimus dose highly varies among Asian kidney transplant recipients. This can be explained by variety of CYP3A5 expression. CYP3A5 genotyping is highly recommended for…
2015 American Transplant Congress
Liver Fabrication Using Whole Organ Scaffold for Transplantable Graft in Large Animal
K. Inomata,¹ H. Yagi,¹ K. Tazima,¹ K. Sugiyama,¹ M. Hieda,¹ T. Hibi,¹ Y. Abe,¹ M. Kitago,¹ M. Shinoda,¹ O. Itano,¹ T. Akaike,² Y. Kitagawa.¹
¹Surgery, Keio University, Tokyo, Japan; ²Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Tokyo, Japan.
Background and aims: Orthotopic liver transplantation is only effective treatment for end-stage liver disease, however it is limited by shortage of donor livers. Therefore, novel…
2015 American Transplant Congress
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function
D. Felix,¹ B. Astor,² D. Hager,¹ A. Djamali.²
¹Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI; ²Department of Medicine - Division of Nephrology, University of Wisconsin Hospital and Clinics, Madison, WI.
The impact of selection of induction immunosuppression agent on incidence of delayed graft function (DGF) remains unclear. A total of 1,980 deceased donor kidney transplant…
2015 American Transplant Congress
Blocking CD40/CD154 Co-Stimulation Prevents Acute Antibody-Mediated Renal Allograft Rejection Induced by Memory CD4 T Cells
V. Gorbacheva, R. Fan, A. Valujskikh.
Immunology, The Cleveland Clinic, Cleveland, OH.
Immunosuppression-resistant alloreactive memory CD4 T cells induce robust responses against organ transplants. In murine heart allograft recipients donor-reactive memory CD4 T cells provide help for…
2015 American Transplant Congress
Controlling for Socioeconomic Barriers Reduces Racial Disparities in Transplant Pursuit
A. Waterman,¹ J. Peipert,¹ C. Kynard-Amerson,¹ A.-M. McSorley,¹ A. Paiva,² M. Robbins,² L. Peace.³
¹David Geffen School of Medicine, UCLA, Los Angeles, CA; ²University of Rhode Island, Kingston, RI; ³Missouri Kidney Program, Columbia, MO.
Compared to White dialysis patients, Black patients experience more socioeconomic barriers (SEBs) including higher financial insecurity and worse health insurance. To examine how SEBs affect…
2015 American Transplant Congress
Moderate KDPI (35-85) and High KDPI (>85) Grafts Yield Similar Graft Function and Survival
A. Gupta,² G. Francos,² C. Gorn,³ A. Shah.¹
¹Surgery, Thomas Jefferson University, Philadelphia, PA; ²Nephrology, Thomas Jefferson University, Philadelphia, PA; ³Transplantation, Thomas Jefferson University, Philadelphia, PA.
Purpose – To study the impact of donor KDPI on post-transplant kidney function and survival.Methods – We reviewed the records of 309 deceased donor kidney…
2015 American Transplant Congress
Risks for Readmission Post-Renal Transplant: A Co-Morbid Condition
M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.
Transplant Institute, Tulane University, New Orleans, LA.
Background: Recently CMS addressed “excessive” readmission rates with a punitive 5% cut in reimbursement. For decades renal transplantation has been highly regulated with published outcomes…
2015 American Transplant Congress
Kidney Transplant Outcomes in Marijuana Users
P. Shrivastava,¹ A. Naik,¹ A. Sakhuja,¹ Y. Lu,¹ Y. Huang,¹ F. Barrantes,² F. Luan,³ S. Kulshrestha,⁴ M. Samaniego.¹
¹Dept of Internal Medicine, University of Michigan, Ann Arbor, MI; ²Presbyterian Kidney Transplantation, Albuquerque, NM; ³Dept of Kidney and Pancreas Transplantation, St. Barnabas Medical Center, Livingston, NJ; ⁴Dept of Internal Medicine, University of Iowa, Iowa City, IA.
Introduction: As Marijuana use is gaining social acceptance, many transplant centers face questions regarding candidacy of users for kidney transplantation. Currently its impact on post-transplantation…